Kauvery Hospital Alwarpet Performs World's First Catheter-Based Treatment for Two Failing Heart Valves in a Man Aged 58 in Hybrid Cath Lab

Kauvery Hospital, Alwarpet, has successfully treated two failing heart valves in a patient without repeat open-heart surgery, in what is believed to be the world’s first reported completely catheter-based treatment following a Ross procedure.

 

Dr. R Anantharaman, Director for Transcatheter Heart Valve Therapies, Dr Mahesh Kumar Medical Superintendent and team of cardiologists and cardiac surgeons

 

The procedure was performed on a 58-year-old man who had undergone a complex heart valve operation nearly 25 years ago. He had previously undergone the Ross procedure, in which the patient’s own pulmonary valve is moved to replace the diseased aortic valve (known as an aortic autograft), while the pulmonary valve is replaced with a donated human valve (known as a pulmonary homograft). Although the Ross procedure provides excellent long-term outcomes, both valves can deteriorate over time and may require further intervention.

 

The patient presented with severe aortic regurgitation, severe pulmonary regurgitation with moderate pulmonary stenosis, severe pulmonary hypertension and moderate mitral regurgitation. He had repeated admissions for heart failure with severe swelling of the legs and abdomen, impaired kidney and liver function, and severe breathlessness. He was unable to sleep comfortably and was in New York Heart Association Class III–IV heart failure.

 

He had consulted multiple centres where repeat open-heart surgery was considered prohibitively high risk because of the complexity of a second operation. Even a catheter-based approach was considered extremely challenging.

 

Following a detailed evaluation using three-dimensional echocardiography and cardiac CT imaging, the multidisciplinary heart team at Kauvery Heart Institute identified the possibility of treating both failing valves through a completely catheter-based approach without repeat open-heart surgery. Since no similar case had been reported in the published medical literature, the treatment strategy was reviewed extensively by the hospital’s heart team led by Dr Rajaram Anantharaman, Director of Transcatheter Heart Valve Therapies and an international panel of experts before proceeding.

 

The pulmonary homograft was initially prepared by placing covered stents, followed by balloon dilatation, before implanting a Medtronic Melody transcatheter pulmonary valve. The failing aortic autograft was then treated with an Edwards Sapien 3 Ultra Resilia balloon-expandable valve. As there was no calcium within the valve to help anchor the replacement valve, the procedure required meticulous planning and precise execution, with AI predictive modeling with virtual Valve implant. It was performed in a hybrid operating room under general anaesthesia with continuous transoesophageal echocardiography guidance.

 

The patient made an uneventful recovery and was discharged after a short stay in the intensive care unit. At his two-week follow-up, his symptoms had improved markedly. The swelling had completely resolved, he had returned to New York Heart Association Class I functional status, was sleeping comfortably, and was able to walk for 20–30 minutes without any limitation.

 

Dr. Rajaram Anantharaman, Director for Transcatheter Heart Valve Therapies Kauvery Heart Institute, Alwarpet, said, “Patients with failure of both the aortic autograft and pulmonary homograft after a Ross procedure have very limited treatment options because repeat surgery carries considerable risk. Careful imaging, meticulous procedural planning and close collaboration across multiple specialties enabled us to successfully replace both valves using a catheter-based approach without reopening the chest. To the best of our knowledge, this is the first reported case of a completely percutaneous double transcatheter Ross rescue strategy in the published world literature. This case opens the possibility of treating carefully selected high-risk patients who otherwise may not have a viable treatment option.“

 

Dr. Aravindan Selvaraj, Co-founder and Executive Director, Kauvery Group of Hospitals, added, “Advanced structural heart interventions are transforming the way complex valve diseases are treated. Performing a procedure of this complexity requires experienced clinical teams, advanced imaging, hybrid operating room facilities and seamless coordination across specialties. This achievement reflects the advanced expertise and infrastructure available at Kauvery Heart Institute and our continued commitment to bringing the latest evidence-based treatment options to patients in India.”

  • Related Posts

    Sentosa Island Transforms into Largest Single Stop for 'BTS THE CITY ARIRANG SINGAPORE'

    From 18 to 20 December, fans can look forward to a 1,500-strong drone light show, at the BTS THE CITY ARIRANG Rave & Drone Party at Sentosa with DJ RAW…

    GoodFlip, a TatvaCare Company, Names Milind Soman as Brand Ambassador, Putting Consistency at the Heart of Metabolic Health

    GoodFlip, TatvaCare’s digital therapeutics platform, today named actor and endurance athlete Milind Soman as its brand ambassador. Soman will represent GoodFlip and its full range of metabolic health programmes, built…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    GoodFlip, a TatvaCare Company, Names Milind Soman as Brand Ambassador, Putting Consistency at the Heart of Metabolic Health

    GoodFlip, a TatvaCare Company, Names Milind Soman as Brand Ambassador, Putting Consistency at the Heart of Metabolic Health

    Sentosa Island Transforms into Largest Single Stop for 'BTS THE CITY ARIRANG SINGAPORE'

    Sentosa Island Transforms into Largest Single Stop for 'BTS THE CITY ARIRANG SINGAPORE'

    Risk Outlook 2027: Converging Global Threats Put Workforce Protection and Business Resilience in Focus

    Risk Outlook 2027: Converging Global Threats Put Workforce Protection and Business Resilience in Focus

    Antara Care Homes' Two Bengaluru Centres Receive NABH Accreditation, Taking its Accredited Centres to Four

    Antara Care Homes' Two Bengaluru Centres Receive NABH Accreditation, Taking its Accredited Centres to Four

    Where CSR Funding Falls Short of India's Biggest Challenges: Sattva Consulting Report Identifies Five Areas for Catalytic Impact

    Happiest Health Launches Happiest Health Digital Business Announces Roadmap of 11 Applications Commits Rs. 500 Crore to Technology Investment

    Happiest Health Launches Happiest Health Digital Business Announces Roadmap of 11 Applications Commits Rs. 500 Crore to Technology Investment